Replies to post #51509 on Biotech Values

[walldiver]

The survival HR at the interim was 0.67. The DSMB then halted the trial and offered Avastin to all of the control arm patients for compassionate/ethical reasons. After the Taxotere-only patients crossed over, the HR increased.